In the midst of the 2014 Ebola outbreak, a drug called ZMapp was one of the most promising treatments for the disease. But now researchers have published a study of the medication in people, and the ...

The drug ZMapp appears to help Ebola patients, but results in a clinical trial fell short of statistical significance because there weren’t enough participants, according to a study published this ...

ZMapp is a cocktail comprised of three antibodies intended to fight Ebola virus and was identified in January 2014. Its development was supported by health agencies around the world. Ebola is a topic ...

The US Department of Health and Human Services (DHHS) says it will shield the manufacturer of the investigational Ebola virus treatment ZMapp from legal liability under a federal law intended to ...

ZMapp, once touted as a miraculous "secret serum" against the deadly Ebola virus, has shown some success but fell short of the bar for effectiveness in a clinical trial, researchers said Wednesday.

According to initial results from a randomized, controlled trial of the experimental Ebola treatment ZMapp, the monoclonal antibody cocktail was well-tolerated and showed promise. Due to decreasing ...